Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress

European Neuropsychopharmacology

Volumn 19, Issue 3, 2009, Pages 215-228

  Bambico, Francis Rodriguez ^a   Nguyen, Nhu Tram ^a,b   Gobbi, Gabriella ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

Author keywords

5 HT1A; Anhedonia; Chronic unpredictable stress; Depression; Dorsal raphe nucleus; Serotonin

Indexed keywords

SEROTONIN 1A RECEPTOR;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DORSAL RAPHE NUCLEUS; HOPELESSNESS; MALE; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; RISK FACTOR; SUGAR INTAKE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; ELECTRIC STIMULATION; FOOD PREFERENCES; MALE; NEURAL INHIBITION; NEURONS; PIPERAZINES; PYRIDINES; RAPHE NUCLEI; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; STRESS, PSYCHOLOGICAL; SUCROSE; SWEETENING AGENTS; TIME FACTORS;

EID: 58949091253     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2008.11.005     Document Type: Article

References (127)

1. Aghajanian G.K., Wang R.Y., and Baraban J. Serotonergic and non-serotonergic neurons of the dorsal raphe: reciprocal changes in firing induced by peripheral nerve stimulation. Brain Res. 153 (1978) 169-175
2. Allers K.A., and Sharp T. Neurochemical and anatomical identification of fast and slow- firing neurons in the rat dorsal raphe nucleus using juxtacellular labeling methods in vivo. Neuroscience 122 (2003) 193-204
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition (1994), American Psychiatric Association, Washington D.C.
4. Arango V., Underwood M.D., Boldrini M., Tamir H., Kassir S.A., Hsiung S., Chen J.J., and Mann J.J. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 25 6 (2001) 892-903
5. Arborelius L., Hawks B.W., Owens M.J., Plotsky P.M., and Nemeroff C.B. Increased responsiveness of presumed 5-HT cells to citalopram in adult rats subjected to prolonged maternal separation relative to brief separation. Psychopharmacology (Berl) 176 (2004) 248-255
6. Aso E., Renoir T., Ledent C., Hamon M., Maldonado R., Lanfumey L., and Valverde O. Lack of CB 1 receptor alters serotonin system: an electrophysiological and in vivo microdialysis study [poster P.2.03]. European College of Neuropsychopharmacology Workshop on Neuropsychopharmacology for Young Scientists in Europe (2008)
7. Aso E., Ozaita A., Valdizán E.M., Ledent C., Pazos A., Maldonado R., and Valverde O. BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. J. Neurochem. 105 2 (2008) 565-572
8. Austin M.C., Janosky J.E., and Murphy H.A. Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Mol. Psychiatry 8 (2003) 324-332
9. Bachis A., Cruz M.I., Nosheny R.L., and Mocchetti I. Chronic unpredictable stress promotes neuronal apoptosis in the cerebral cortex. Neurosci. Lett. 442 2 (2008) 104-108
10. Bambico F.R., and Gobbi G. The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. Expert Opin. Ther. Targets 12 11 (2008) 1347-1366
11. Bambico F.R., Katz N., Debonnel G., and Gobbi G. Cannabinoids elicit antidepressant-like behaviour and activate serotonergic neurons through the medial prefrontal cortex. J. Neurosci. 27 43 (2007) 11700-11711
12. Banasr M., and Duman R.S. Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol. Psychiatry 64 10 (2008) 863-870
13. Baraban J.M., and Aghajanian G.K. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19 (1980) 355-363
14. Bekris S., Antoniou K., Daskas S., and Papadopoulou-Daifoti Z. Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. Behav. Brain Res. 161 (2005) 45-59
15. Bhagwagar Z., Rabiner E.A., Sargent P.A., Grasby P.M., and Cowen P.J. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol. Psychiatry 9 4 (2004) 386-392
16. Bielajew C., Konkle A.T., Kentner A.C., Baker S.L., Stewart A., Hutchins A.A., Santa-Maria Barbagallo L., and Fouriezos G. Strain and gender specific effects in the forced swim test: effects of previous stress exposure. Stress 6 4 (2003) 269-280
17. Blier P., and de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15 7 (1994) 220-226
18. Bondi C.O., Rodriguez G., Gould G.G., Frazer A., and Morilak D.A. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology 33 2 (2007) 320-331
19. Borckardt J.J., Anderson B., Andrew Kozel F., Nahas Z., Richard Smith A., Jackson Thomas K., Kose S., and George M.S. Acute and long-term VNS effects on pain perception in a case of treatment-resistant depression. Neurocase 12 (2006) 216-220
20. Bosker F.J., Klompmakers A., and Westenberg H.G. Postsynaptic 5-HT1A receptors mediate 5-hydroxytryptamine release in the amygdala through a feedback to the caudal linear raphe. Eur. J. Pharmacol. 333 2-3 (1997) 147-157
21. Bunney B.S., and Grace A.A. Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sci. 23 16 (1978) 1715-1727
22. Carpenter L.L., Tyrka A.R., McDougle C.J., Malison R.T., Owens M.J., Nemeroff C.B., and Price L.H. Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology 29 (2004) 777-784
23. Celada P., Siuciak J.A., Tran T.M., Altar C.A., and Tepper J.M. Local infusion of brain-derived neurotrophic factor modifies the firing pattern of dorsal raphé serotonergic neurons. Brain Res. 712 2 (1996) 293-298
24. Celada P., Puig M.V., Casanovas J.M., Guillazo G., and Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors. J. Neurosci. 21 24 (2001) 9917-9929
25. Chalmers D.T., Lovenberg T.W., and De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15 (1995) 6340-6350
26. Clark M.S., McDevitt R.A., Hoplight B.J., and Neumaier J.F. Chronic low dose ovine corticotropin releasing factor or urocortin II into the rostral dorsal raphe alters exploratory behavior and serotonergic gene expression in specific subregions of the dorsal raphe. Neuroscience 146 (2007) 1888-1905
27. Conductier G., Dusticier N., Lucas G., Côté F., Debonnel G., Daszuta A., Dumuis A., Nieoullon A., Hen R., Bockaert J., and Compan V. Adaptive changes in serotonin neurons of the raphe nuclei in 5-HT(4) receptor knock-out mouse. Eur. J. Neurosci. 24 (2006) 1053-1062
28. Contarino A., Heinrichs S.C., and Gold L.H. Understanding corticotropin releasing factor neurobiology: contributions from mutant mice. Neuropeptides 33 (1999) 1-12
29. Cowen P.J., Power A.C., Ware C.J., and Anderson I.M. 5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone. Br. J. Psychiatry 164 3 (1994) 372-379
30. Cunningham K.A. Modulation of serotonin function by acute and chronic cocaine: neurophysiological analysis. In: Hammer Jr. R.P. (Ed). The neurobiology of cocaine: cellular and molecular mechanisms (1995), CRC Press, Boca Raton, Florida 121-123
31. Cunningham K.A., and Lakoski J.M. The interaction of cocaine with serotonin dorsal raphe neurons: single-unit extracellular recording studies. Neuropsychopharmacology 3 (1990) 41-50
32. Dahlstrom A., and Fuxe K. Localization of monoamines in the lower brain stem. Experientia 20 (1964) 398-399
33. D'Aquila P.S., Brain P., and Willner P. Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression. Physiol. Behav. 56 5 (1994) 861-867
34. de Boer T. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. Int. Clin. Psychopharmacol. 10 Suppl 4 (1996) 19-23
35. Descarries L., Watkins K.C., Garcia S., and Beaudet A. The serotonin neurons in nucleus raphe dorsalis of adult rat: a light and electron microscope radioautographic study. J. Comp. Neurol. 207 (1982) 239-254
36. Deussing J.M. Animal models of depression. Drug Discovery Today: Disease Models 3 4 (2006) 375-383
37. Dirks A., Groenink L., Bouwknecht J.A., Hijzen T.H., Van Der Gugten J., Ronken E., Verbeek J.S., Veening J.G., Dederen P.J., Korosi A., Schoolderman L.F., Roubos E.W., and Olivier B. Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations. Eur. J. Neurosci. 16 (2002) 1751-1760
38. Dorr A.E., and Debonnel G. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J. Pharmacol. Exp. Ther. 318 (2006) 890-898
39. Drevets W.C., Thase M.E., Moses-Kolko E.L., Price J., Frank E., Kupfer D.J., and Mathis C. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl. Med. Biol. 34 7 (2007) 865-877
40. Fabre V., Beaufour C., Evrard A., Rioux A., Hanoun N., Lesch K.P., Murphy D.L., Lanfumey L., Hamon M., and Martres M.P. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur. J. Neurosci. 12 7 (2000) 2299-2310
41. Fairchild G., Leitch M.M., and Ingram C.D. Acute and chronic effects of corticosterone on 5-HT1A receptor-mediated autoinhibition in the rat dorsal raphe nucleus. Neuropharmacology 45 (2003) 925-934
42. Froger N., Palazzo E., Boni C., Hanoun N., Saurini F., Joubert C., Dutriez-Casteloot I., Enache M., Maccari S., Barden N., Cohen-Salmon C., Hamon M., and Lanfumey L. Neurochemical and behavioral alterations in glucocorticoid receptor-impaired transgenic mice after chronic mild stress. J. Neurosci. 24 (2004) 2787-2796
43. Gartside S.E., Hajos-Korcsok E., Bagdy E., Harsing Jr. L.G., Sharp T., and Hajos M. Neurochemical and electrophysiological studies on the functional significance of burst firing in serotonergic neurons. Neuroscience 98 2 (2000) 295-300
44. Gartside S.E., Johnson D.A., Leitch M.M., Troakes C., and Ingram C.D. Early life adversity programs changes in central 5-HT neuronal function in adulthood. Eur. J. Neurosci. 17 (2003) 2401-2408
45. Gobbi G., Murphy D.L., Lesch K., and Blier P. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J. Pharmacol. Exp. Ther. 296 (2001) 987-995
46. Gobbi G., Bambico F.R., Mangieri R., Bortolato M., Campolongo P., Solinas M., Cassano T., Morgese M.G., Debonnel G., Duranti A., Tontini A., Tarzia G., Mor M., Trezza V., Goldberg S.R., Cuomo V., and Piomelli D. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Natl. Acad. Sci. U.S.A. 102 51 (2005) 18620-18625
47. Gobbi G., and Blier P. Effect of neurokinin-1 receptor antagonists on serotoninergic noradrenergic and hippocampal neurons: comparison with antidepressant drugs. Peptides 26 8 (2005) 1383-1393
48. Grippo A.J., Sullivan N.R., Damjanoska K.J., Crane J.W., Carrasco G.A., Shi J., Chen Z., Garcia F., Muma N.A., and Van de Kar L.D. Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats. Psychopharmacology (Berl) 179 4 (2005) 769-780
49. Groenink L., Dirks A., Verdouw P.M., Schipholt M., Veening J.G., van der Gugten J., and Olivier B. HPA axis dysregulation in mice overexpressing corticotropin releasing hormone. Biol. Psychiatry 51 (2002) 875-881
50. Groenink L., Pattij T., De Jongh R., Van der Gugten J., Oosting R.S., Dirks A., and Olivier B. 5-HT1A receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety. Eur. J. Pharmacol. 463 (2003) 185-197
51. Groenink L., Dirks A., Verdouw P.M., de Graaff M., Peeters B.W., Millan M.J., and Olivier B. CRF(1) not glucocorticoid receptors mediate prepulse inhibition deficits in mice overexpressing CRF. Biol. Psychiatry 63 4 (2007) 360-368
52. Guimarães F.S., Del Bel E.A., Padovan C.M., Netto S.M., and de Almeida R.T. Hippocampal 5-HT receptors and consolidation of stressful memories. Behav. Brain Res. 58 1-2 (1993) 133-139
53. Haddjeri N., and Blier P. Sustained blockade of neurokinin-1 receptors enhances serotonin neurotransmission. Biol. Psychiatry 50 (2001) 191-199
54. Haddjeri N., Blier P., and de Montigny C. Effect of the alpha-2 adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain. J. Pharmacol. Exp. Ther. 277 2 (1996) 861-871
55. Hajos M., Hajos-Korcsok E., and Sharp T. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat. Br. J. Pharmacol. 126 (1999) 1741-1750
56. Hall H., Lundkvist C., Halldin C., Farde L., Pike V.W., McCarron J.A., Fletcher A., Cliffe I.A., Barf T., Wikström H., and Sedvall G. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Res. 745 1-2 (1997) 96-108
57. Hammack S.E., Pepin J.L., DesMarteau J.S., Watkins L.R., and Maier S.F. Low doses of corticotropin-releasing hormone injected into the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress. Behav. Brain Res. 147 (2003) 55-64
58. Heinrichs S.C., Lapsansky J., Lovenberg T.W., De Souza E.B., and Chalmers D.T. Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior. Regul. Pept. 71 (1997) 15-21
59. Heinrichs S.C., Min H., Tamraz S., Carmouche M., Boehme S.A., and Vale W.W. Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated. Psychoneuroendocrinology 22 (1997) 215-224
60. Heurteaux C., Lucas G., Guy N., El Yacoubi M., Thummler S., Peng X.D., Noble F., Blondeau N., Widmann C., Borsotto M., Gobbi G., Vaugeois J.M., Debonnel G., and Lazdunski M. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat. Neurosci. 9 (2006) 1134-1141
61. Hirani K., Khisti R.T., and Chopde C.T. Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3 alpha-hydroxy-5 alpha-pregnan-20-one. Neuropharmacology 43 8 (2002) 1339-1350
62. Hirvonen J., Karlsson H., Kajander J., Lepola A., Markkula J., Rasi-Hakala H., Någren K., Salminen J.K., and Hietala J. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int. J. Neuropsychopharmacol. 11 4 (2008) 465-476
63. Holmes A. Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease. Neurosci. Biobehav. Rev. 32 7 (2008) 1293-1314
64. Joëls M., Karst H., Alfarez D., Heine V.M., Qin Y., van Riel E., Verkuyl M., Lucassen P.J., and Krugers H.J. Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus. Stress 7 (2004) 221-231
65. Kang M., Pyun K.H., Jang C.G., Kim H., Bae H., and Shim I. Nelumbinis Semen reverses a decrease in hippocampal 5-HT release induced by chronic mild stress in rats. J. Pharm. Pharmacol. 57 5 (2005) 651-656
66. Katz R.J., Roth K.A., and Carroll B.J. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci. Biobehav. Rev. 5 (1981) 247-251
67. Kendler K.S., Karkowski L.M., and Prescott C.A. Causal relationship between stressful life events and the onset of major depression. Am. J. Psychiatry 156 (1999) 837-841
68. Kim H., Whang W.W., Kim H.T., Pyun K.H., Cho S.Y., Hahm D.H., Lee H.J., and Shim I. Expression of neuropeptide Y and cholecystokinin in the rat brain by chronic mild stress. Brain Res. 983 1-2 (2003) 201-208
69. Kinney G.G., Vogel G.W., and Feng P. Decreased dorsal raphe nucleus neuronal activity in adult chloral hydrate anesthetized rats following neonatal clomipramine treatment: implications for endogenous depression. Brain Res. 756 1-2 (1997) 68-75
70. Kirby L.G., Rice K.C., and Valentino R.J. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22 (2000) 148-162
71. Kishimoto T., Radulovic J., Radulovic M., Lin C.R., Schrick C., Hooshmand F., Hermanson O., Rosenfeld M.G., and Spiess J. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat. Genet. 24 4 (2000) 415-419
72. Lanfumey L., Pardon M.C., Laaris N., Joubert C., Hanoun N., Hamon M., and Cohen-Salmon C. 5-HT1A autoreceptor desensitization by chronic ultramild stress in mice. Neuroreport 10 16 (1999) 3369-3374
73. Li Q., Wichems C., Heils A., Lesch K.P., and Murphy D.L. Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences. J. Neurosci. 20 21 (2000) 7888-7895
74. Linnér L., Wiker C., Arborelius L., Schalling M., and Svensson T.H. Selective noradrenaline reuptake inhibition enhances serotonergic neuronal activity and transmitter release in the rat forebrain. J. Neural. Transm. 111 2 (2004) 127-139
75. Lira A., Zhou M., Castanon N., Ansorge M.S., Gordon J.A., Francis J.H., Bradley-Moore M., Lira J., Underwood M.D., Arango V., Kung H.F., Hofer M.A., Hen R., and Gingrich J.A. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol. Psychiatry 54 10 (2003) 960-971
76. Lodge D.J., and Grace A.A. The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation. Neuropsychopharmacology 31 (2006) 1356-1361
77. López J.F., Vázquez D.M., Chalmers D.T., and Watson S.J. Regulation of 5-HT receptors and the hypothalamic-pituitary-adrenal axis. Implications for the neurobiology of suicide. Ann. N.Y. Acad. Sci. 836 (1997) 106-134
78. Luo D.D., An S.C., and Zhang X. Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress. Brain Res. Bull. 77 1 (2008) 8-12
79. Martín-Ruiz R., and Ugedo L. Electrophysiological evidence for postsynaptic 5-HT(1A) receptor control of dorsal raphe 5-HT neurones. Neuropharmacology 41 1 (2001) 72-78
80. Maudhuit C., Hamon M., and Adrien J. Electrophysiological activity of raphe dorsalis serotoninergic neurones in a possible model of endogenous depression. Neuroreport 6 4 (1995) 681-684
81. Meltzer C.C., Price J.C., Mathis C.A., Butters M.A., Ziolko S.K., Moses-Kolko E., Mazumdar S., Mulsant B.H., Houck P.R., Lopresti B.J., Weissfeld L.A., and Reynolds C.F. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 29 12 (2004) 2258-2265
82. Mo B., Feng N., Renner K., and Forster G. Restraint stress increases serotonin release in the central nucleus of the amygdala via activation of corticotropin-releasing factor receptors. Brain Res. Bull. 76 5 (2008) 93-98
83. Moreau J.L., Jenck F., Martin J.R., Mortas P., and Haefely W.E. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. Eur. Neuropsychopharmacol. 2 (1992) 43-49
84. Neumaier J.F., Edwards E., and Plotsky P.M. 5-HT(1B) mrna regulation in two animal models of altered stress reactivity. Biol. Psychiatry 51 (2002) 902-908
85. Neumeister A., Bain E., Nugent A.C., Carson R.E., Bonne O., Luckenbaugh D.A., Eckelman W., Herscovitch P., Charney D.S., and Drevets W.C. Reduced serotonin type 1A receptor binding in panic disorder. J. Neurosci. 24 3 (2004) 589-591
86. Nielsen C.K., Arnt J., and Sánchez C. Intracranial self-stimulation and sucrose intake differ as hedonic measures following chronic mild stress: interstrain and interindividual differences. Behav. Brain Res. 107 1-2 (2000) 21-33
87. Orsetti M., Canonico P.L., Dellarole A., Colella L., Di Brisco F., and Ghi P. Quetiapine prevents anhedonia induced by acute or chronic stress. Neuropsychopharmacology 32 8 (2007) 1783-1790
88. Papp M., Moryl E., and Willner P. Pharmacological validation of the chronic mild stress model of depression. Eur. J. Pharmacol. 296 (1996) 129-136
89. Parsons L.H., Koob G.F., and Weiss F. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J. Pharmacol. Exp. Ther. 274 (1995) 1182-1191
90. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, San Diego
91. Pazos A., Probst A., and Palacios J.M. Serotonin receptors in the human brain-III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21 1 (1987) 97-122
92. Pernar L., Curtis A.L., Vale W.W., Rivier J.E., and Valentino R.J. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J. Neurosci. 24 (2004) 1305-1311
93. Phillips A.G., and Barr A.M. Effects of chronic mild stress on motivation for sucrose: mixed messages. Psychopharmacology (Berl) 134 (1997) 361-366
94. Pistis M., Muntoni A.L., Gessa G., and Diana M. Effects of acute, chronic ethanol and withdrawal on dorsal raphe neurons: electrophysiological studies. Neuroscience 79 (1997) 171-176
95. Pitchot W., Hansenne M., Pinto E., Reggers J., Fuchs S., and Ansseau M. 5-Hydroxytryptamine 1A receptors, major depression, and suicidal behavior. Biol. Psychiatry 58 11 (2005) 854-858
96. Potter E., Sutton S., Donaldson C., Chen R., Perrin M., Lewis K., Sawchenko P.E., and Vale W. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8777-9781
97. Price M.L., and Lucki I. Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J. Neurosci. 21 (2001) 2833-2841
98. Price M.L., Curtis A.L., Kirby L.G., Valentino R.J., and Lucki I. Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 18 (1998) 492-502
99. Pruessner M., Hellhammer D.H., Pruessner J.C., and Lupien S.J. Self-reported depressive symptoms and stress levels in healthy young men: associations with the cortisol response to awakening. Psychosom. Med. 65 (2003) 92-99
100. Rabiner E.A., Bhagwagar Z., Gunn R.N., Cowen P.J., and Grasby P.M. Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depression?. Neuropsychopharmacology 29 9 (2004) 1688-1698
101. Riad M., Zimmer L., Rbah L., Watkins K.C., Hamon M., and Descarries L. Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat. J. Neurosci. 24 23 (2004) 5420-5426
102. Riad M., Rbah L., Verdurand M., Aznavour N., Zimmer L., and Descarries L. Unchanged density of 5-HT(1A) autoreceptors on the plasma membrane of nucleus raphe dorsalis neurons in rats chronically treated with fluoxetine. Neuroscience. 151 3 (2008) 692-700
103. Rioja J., Santín L.J., Doña A., de Pablos L., Minano F.J., Gonzalez-Baron S., and Aguirre J.A. 5-HT1A receptor activation counteracts c-Fos immunoreactivity induced in serotonin neurons of the raphe nuclei after immobilization stress in the male rat. Neurosci. Lett. 397 3 (2006) 190-195
104. Risbrough V.B., Hauger R.L., Pelleymounter M.A., and Geyer M.A. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology (Berl) 170 (2003) 178-187
105. Rodríguez Echandía E.L., Gonzalez A.S., Cabrera R., and Fracchia L.N. A further analysis of behavioral and endocrine effects of unpredictable chronic stress. Physiol. Behav. 43 6 (1988) 789-795
106. Sakanaka M., Shibasaki T., and Lederis K. Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidasediaminobenzidine method. J. Comp. Neurol. 260 (1987) 256-298
107. Santarelli L., Gobbi G., Debs P.C., Sibille E.T., Blier P., Hen R., and Heath M.J. Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 1912-1917
108. Sargent P.A., Kjaer K.H., Bench C.J., Rabiner E.A., Messa C., Meyer J., Gunn R.N., Grasby P.M., and Cowen P.J. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch. Gen. Psychiatry 57 2 (2000) 174-180
109. Schulteis G., Markou A., Cole M., and Koob G.F. Decreased brain reward produced by ethanol withdrawal. Proc. Natl. Acad. Sci. U.S.A. 92 13 (1995) 5880-5884
110. Steciuk M., Kram M., Kramer G.L., and Petty F. Acute stress does not alter 5-HT1A receptor density. Prog. Neuropsychopharmacol. Biol. Psychiatry 24 1 (2000) 155-161
111. Steinbusch H.W. Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 6 (1981) 557-618
112. Steiner M.A., Wanisch K., Monory K., Marsicano G., Borroni E., Bächli H., Holsboer F., Lutz B., and Wotjak C.T. Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. Pharmacogenomics J. 8 3 (2008) 196-208
113. Stockmeier C.A., Shapiro L.A., Dilley G.E., Kolli T.N., Friedman L., and Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J. Neurosci. 18 (1998) 7394-7401
114. Swanson L.W., Sawchenko P.E., Rivier J., and Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36 (1983) 165-186
115. Swiergiel A.H., Zhou Y., and Dunn A.J. Effects of chronic footshock, restraint and corticotropin-releasing factor on freezing, ultrasonic vocalization and forced swim behavior in rats. Behav. Brain Res. 183 (2007) 178-187
116. Temel Y., Boothman L.J., Blokland A., Magill P.J., Steinbusch H.W., Visser-Vandewalle V., and Sharp T. Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. Proc. Natl. Acad. Sci. U.S.A. 104 43 (2007) 17087-17092
117. Urbain N., Creamer K., and Debonnel G. Electrophysiological diversity of the dorsal raphe cells across the sleep-wake cycle of the rat. J. Physiol. 573 Pt 3 (2006) 679-695
118. Vandermaelen C.P., and Aghajanian G.K. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res. 289 (1983) 109-119
119. Vicentic A., Francis D., Moffett M., Lakatos A., Rogge G., Hubert G.W., Harley J., and Kuhar M.J. Maternal separation alters serotonergic transporter densities and serotonergic 1A receptors in rat brain. Neuroscience 140 (2006) 355-365
120. Watanabe Y., Stone E., and McEwen B.S. Induction and habituation of c-fos and zif/268 by acute and repeated stressors. Neuroreport 5 11 (1994) 1321-1324
121. Weiss F., Parsons L.H., and Markou A. Neurochemistry of cocaine withdrawal. In: Hammer Jr. R.P. (Ed). The neurobiology of cocaine: cellular and molecular mechanisms (1995), CRC Press, Boca Raton, Florida 163-180
122. Weiss F., Parsons L.H., Schulteis G., Hyytia P., Lorang M.T., Bloom F.E., and Koob G.F. Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J. Neurosci. 16 (1996) 3474-3485
123. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 134 (1997) 319-329
124. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural neurobiological concordance in the effects of CMS. Neuropsychobiology 52 2 (2005) 90-110
125. Willner P., Towell A., Sampson D., Sophokleous S., and Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 93 (1987) 358-364
126. Willner P., Muscat R., and Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci. Biobehav. Rev. 16 (1992) 525-534
127. Ziabreva I., Poeggel G., Schnabel R., and Braun K. Separation-induced receptor changes in the hippocampus and amygdala of Octodon degus: influence of maternal vocalizations. J. Neurosci. 23 (2003) 5329-5336